The Europe Direct fed Microbials Market was worth USD 249.45 million in 2021 and estimated to be growing at a CAGR of 7.5%, to reach USD 359.94 million by 2026. Probiotics is another term for this class of feed additives. Probiotics or DFM have been appeared to enhance animal performance in controlled studies.
Europe Direct Fed Microbials Market Drivers:
The market is driven by factors such as increase in awareness about sustain quality and safety, rising demand for fabricated animal nourish, growth in demand for animal protein, changes in farming practices and technology, and replacing anti-toxin growth promoters (AGPs) with direct-fed microbials. The continuous rise in the population has also resulted in an increase in the demand for food and the necessity for direct-fed microbials, to increase meat and milk production in a sustainable manner. A decline in the usage of anti-infection growth promoters across the globe is driving the sales of direct-fed microbials. Factors such as, high cost of direct-feed microbials and low shelf life are prompting an ascent in the cost of production and limiting the development of the market.
Europe Direct Fed Microbials Market – By Type:
Lactic Acid Bacteria
Europe Direct Fed Microbials Market – By Livestock:
Europe Direct Fed Microbials Market – By Form:
Geographical Analysis:
On the basis of geography, the Europe market is analysed under various regions namely U.K, Spain, Germany, Italy and France. Europe represented the second-biggest market of the overall industry in 2015. The utilization of direct-fed microbials in animal feed is relied upon to increase at a faster pace in Europe and the Asia-Pacific regions because of the rising demand.
Key Players:
Key players in the market are Archer Daniels Midland Company, E.I. Dupont De Nemours and Company, Koninklijke DSM N.V., Novozymes, Chr. Hansen Holding A/S, Kemin Industries, Inc., Biomin Holding GmbH, Lallemand, Inc., Novus International, Inc., Bio-Vet.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Lactic Acid Bacteria
5.1.2.1 Lactobacilli
5.1.2.2 Bifidobacteria
5.1.2.3 Streptococcus thermophilus
5.1.3 Bacillus subtilis
5.1.3.1 Bacillus licheniformis
5.1.4 Other Bacteria
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Livestock
5.2.1 Introduction
5.2.2 Swine
5.2.3 Poultry
5.2.4 Ruminants
5.2.5 Aquatic Animals
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By Livestock
5.2.8 Market Attractiveness Analysis,
5.2.9 Market Share Analysis, By Livestock
5.3 Form
5.3.1 Introduction
5.3.2 Dry Form
5.3.3 Liquid Form
5.3.4 Y-o-Y Growth Analysis, By Form
5.3.5 Market Attractiveness Analysis, By Form
5.3.6 Market Share Analysis, By Form
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Livestock
6.1.3.4 By Form
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Livestock
6.1.4.4 By Form
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Livestock
6.1.5.4 By Form
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Archer Daniels Midland Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 E.I. Dupont De Nemours and Company
8.3 Koninklijke DSM N.V.
8.4 Novozymes
8.5 Chr. Hansen Holding A/S
8.6 Kemin Industries, Inc.
8.7 Biomin Holding GmbH
8.8 Lallemand, Inc.
8.9 Novus International, Inc.
8.10 Bio-Vet
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
